A phase I study of CPI-613 (devimistat) in combination with chemoradiation in patients with pancreatic adenocarcinoma.

Authors

Mandana Kamgar

Mandana Kamgar

Medical College of Wisconsin, Milwaukee, WI;

Mandana Kamgar , Husain Yar Khan , Amro Aboukameel , Sahar Bannoura , Brian Y. Chung , Aniko Szabo , Yiwei Li , Mohammed Najeeb Al Hallak , Philip Agop Philip , Ben George , Kathleen K. Christians , Douglas B. Evans , Susan Tsai , Beth Erickson , Sanjeev Luther , Asfar S. Azmi , William A. Hall

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05325281

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr TPS760)

DOI

10.1200/JCO.2023.41.4_suppl.TPS760

Abstract #

TPS760

Poster Bd #

P16

Abstract Disclosures